ArticleWorld journal of otorhinolaryngology - head and neck surgery2026
AI-Powered TAT-Net Hyperspectral Imaging for Rapid and Accurate Differentiation of Sinonasal Inverted Papilloma and Malignancy.
Article in World journal of otorhinolaryngology - head and neck surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Sinonasal inverted papilloma (IP) and malignancies share overlapping clinical and endoscopic features, and conventional histopathology frequently requires time-consuming adjunct immunohistochemistry. Hyperspectral imaging (HSI) can capture subtle spectral changes associated with malignant transformation that are not apparent on routine hematoxylin-eosin (H&E) staining. Methods: In this retrospective single-center study, 176 H&E-stained surgical specimens from 176 patients (89 with IP and 87 with sinonasal malignancies) were allocated at the patient/specimen level to training, validation, and test sets in a 6:2:2 ratio before any hyperspectral data processing. Hyperspectral calibration, selection of regions of interest (ROIs), spectral preprocessing, feature extraction, and quality control yielded 9,296 eligible ROI-level hyperspectral samples: 5,578 in the training set, 1,859 in the validation set, and 1,859 in the test set. Joint spectral-texture features were evaluated using several reference deep-learning models and a Transformer-Attention-based Network (TAT-Net). The primary outcome was the area under the receiver operating characteristic curve (AUC) in the test set. Results: HSI revealed distinct spectral signatures between IP and sinonasal malignancies. All deep learning models demonstrated good discriminative performance (AUCs ≥ 0.85), with TAT-Net achieving the best overall performance. On the independent test set, TAT-Net achieved an AUC of 0.9656 (95% CI: 0.9571-0.9741) for distinguishing between IP and sinonasal malignancies. Conclusion: AI-powered TAT-Net analysis of HSI enables rapid and accurate differentiation between IP and sinonasal malignancies on routine H&E sections. This approach has the potential to shorten diagnostic workflows, support early decision-making, and help standardize the evaluation of sinonasal tumors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.